JPS5821621A - ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤 - Google Patents

ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤

Info

Publication number
JPS5821621A
JPS5821621A JP56120459A JP12045981A JPS5821621A JP S5821621 A JPS5821621 A JP S5821621A JP 56120459 A JP56120459 A JP 56120459A JP 12045981 A JP12045981 A JP 12045981A JP S5821621 A JPS5821621 A JP S5821621A
Authority
JP
Japan
Prior art keywords
tnf
cells
human
animal
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56120459A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6245208B2 (sl
Inventor
Masakazu Mihashi
三橋　正和
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Mochida Pharmaceutical Co Ltd
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Mochida Pharmaceutical Co Ltd
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Mochida Pharmaceutical Co Ltd, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority to JP56120459A priority Critical patent/JPS5821621A/ja
Priority to SE8204382A priority patent/SE8204382L/xx
Priority to FR8212541A priority patent/FR2513124B1/fr
Priority to IT48855/82A priority patent/IT1196549B/it
Priority to AU86200/82A priority patent/AU560793B2/en
Priority to CH4420/82A priority patent/CH664974A5/fr
Priority to KR8203215A priority patent/KR870001433B1/ko
Priority to DE3249946A priority patent/DE3249946C2/de
Priority to DE3227262A priority patent/DE3227262C3/de
Priority to AT0283582A priority patent/AT387980B/de
Priority to US06/400,487 priority patent/US4495282A/en
Priority to GB08221100A priority patent/GB2106117B/en
Priority to ES514210A priority patent/ES8308923A1/es
Priority to CA000408532A priority patent/CA1213544A/en
Publication of JPS5821621A publication Critical patent/JPS5821621A/ja
Priority to JP62028311A priority patent/JP2518635B2/ja
Priority to JP62028310A priority patent/JP2518634B2/ja
Publication of JPS6245208B2 publication Critical patent/JPS6245208B2/ja
Priority to SE9000532A priority patent/SE9000532L/xx
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP56120459A 1981-07-21 1981-07-31 ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤 Granted JPS5821621A (ja)

Priority Applications (17)

Application Number Priority Date Filing Date Title
JP56120459A JPS5821621A (ja) 1981-07-31 1981-07-31 ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤
SE8204382A SE8204382L (sv) 1981-07-21 1982-07-19 Sett att framstella malcellysfaktor och anvendning derav
FR8212541A FR2513124B1 (fr) 1981-07-21 1982-07-19 Production et applications du facteur de lyse des cellules-cibles
IT48855/82A IT1196549B (it) 1981-07-21 1982-07-20 Procedimento per la produzione del fattore di lisi cellule bersaglio (tclf),prodotto ottenuto a suo impiego in terapia clinica,in particolare come agente citolitico antitumurale
AU86200/82A AU560793B2 (en) 1981-07-21 1982-07-20 Production of target cell lysis factor
CH4420/82A CH664974A5 (fr) 1981-07-21 1982-07-20 Production du facteur de lyse des cellules-cibles.
KR8203215A KR870001433B1 (ko) 1981-07-21 1982-07-20 적상적혈구(的狀赤血球) 붕괴인자의 제조 방법
AT0283582A AT387980B (de) 1981-07-21 1982-07-21 Verfahren zur herstellung eines die aufloesung menschlicher zellen bewirkenden faktors
DE3227262A DE3227262C3 (de) 1981-07-21 1982-07-21 Verfahren zur Herstellung von menschlichem Tumor-Nekrose-Faktor und menschlicher Tumor-Nekrose-Faktor
DE3249946A DE3249946C2 (de) 1981-07-21 1982-07-21 hTNF-haltiges therapeutisches Mittel gegen maligne Tumoren und dessen Verwendung
US06/400,487 US4495282A (en) 1981-07-21 1982-07-21 Process for producing target cell lysis factor and uses therewith
GB08221100A GB2106117B (en) 1981-07-21 1982-07-21 Process for producing target cell lysis factor
ES514210A ES8308923A1 (es) 1981-07-21 1982-07-21 Un procedimiento para la produccion de tclf.
CA000408532A CA1213544A (en) 1981-07-31 1982-07-30 Process for producing target cell lysis factor and uses therewith
JP62028311A JP2518635B2 (ja) 1981-07-31 1987-02-12 ヒト ツモア・ネクロシス・フアクタ−
JP62028310A JP2518634B2 (ja) 1981-07-31 1987-02-12 ヒト ツモア・ネクロシス・フアクタ−の製造方法
SE9000532A SE9000532L (sv) 1981-07-21 1990-02-14 Farmaceutisk tclf-komposition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56120459A JPS5821621A (ja) 1981-07-31 1981-07-31 ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP62028311A Division JP2518635B2 (ja) 1981-07-31 1987-02-12 ヒト ツモア・ネクロシス・フアクタ−
JP62028310A Division JP2518634B2 (ja) 1981-07-31 1987-02-12 ヒト ツモア・ネクロシス・フアクタ−の製造方法

Publications (2)

Publication Number Publication Date
JPS5821621A true JPS5821621A (ja) 1983-02-08
JPS6245208B2 JPS6245208B2 (sl) 1987-09-25

Family

ID=14786690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56120459A Granted JPS5821621A (ja) 1981-07-21 1981-07-31 ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤

Country Status (1)

Country Link
JP (1) JPS5821621A (sl)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5888322A (ja) * 1981-11-21 1983-05-26 Hayashibara Biochem Lab Inc 標的細胞障害性因子を含有する悪性腫瘍治療剤とその製造方法
JPS60252496A (ja) * 1984-04-06 1985-12-13 Asahi Chem Ind Co Ltd 新規なヒト生理活性ポリペプチド
JPS6140221A (ja) * 1984-07-05 1986-02-26 ジエネンテク，インコ−ポレイテツド 腫瘍壊死因子
JPS6248634A (ja) * 1985-07-23 1987-03-03 Mochida Pharmaceut Co Ltd 新規アミノ酸組成物、その製造方法及び該アミノ酸組成物を含有する医療組成物
JPS62500631A (ja) * 1984-10-15 1987-03-19 カイロン　コーポレイション ヒト腫瘍壊死因子

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5816687A (ja) * 1981-07-21 1983-01-31 Hayashibara Biochem Lab Inc リンホトキシンの製造方法
GB2106117A (en) * 1981-07-21 1983-04-07 Mochida Pharm Co Ltd Process for producing target cell lysis factor
JPS6011890A (ja) * 1983-06-30 1985-01-22 富士通株式会社 イメ−ジメモリ制御方式

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5816687A (ja) * 1981-07-21 1983-01-31 Hayashibara Biochem Lab Inc リンホトキシンの製造方法
GB2106117A (en) * 1981-07-21 1983-04-07 Mochida Pharm Co Ltd Process for producing target cell lysis factor
JPS6011890A (ja) * 1983-06-30 1985-01-22 富士通株式会社 イメ−ジメモリ制御方式

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5888322A (ja) * 1981-11-21 1983-05-26 Hayashibara Biochem Lab Inc 標的細胞障害性因子を含有する悪性腫瘍治療剤とその製造方法
JPS60252496A (ja) * 1984-04-06 1985-12-13 Asahi Chem Ind Co Ltd 新規なヒト生理活性ポリペプチド
JPH025760B2 (sl) * 1984-04-06 1990-02-05 Asahi Chemical Ind
JPS6140221A (ja) * 1984-07-05 1986-02-26 ジエネンテク，インコ−ポレイテツド 腫瘍壊死因子
JPH083061A (ja) * 1984-07-05 1996-01-09 Genentech Inc 腫瘍壊死因子含有組成物
JPS62500631A (ja) * 1984-10-15 1987-03-19 カイロン　コーポレイション ヒト腫瘍壊死因子
JPS6248634A (ja) * 1985-07-23 1987-03-03 Mochida Pharmaceut Co Ltd 新規アミノ酸組成物、その製造方法及び該アミノ酸組成物を含有する医療組成物

Also Published As

Publication number Publication date
JPS6245208B2 (sl) 1987-09-25

Similar Documents

Publication Publication Date Title
KR870001149B1 (ko) 인체 콜로니 자극인자의 제조방법
DK153848B (da) Fremgangsmaade til fremstilling af interferon
JPS631296B2 (sl)
JPH01502315A (ja) 白血球を培養する方法
JPS6227048B2 (sl)
JPS5852634B2 (ja) ウロキナ−ゼの製造法
JPS5821621A (ja) ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤
JPS58107197A (ja) ツモアネクロシスフアクタ−の製造方法
JPS5816687A (ja) リンホトキシンの製造方法
JPS5888322A (ja) 標的細胞障害性因子を含有する悪性腫瘍治療剤とその製造方法
JPS5823793A (ja) ヒトｔ細胞増殖因子の製造方法
JPS5815921A (ja) 抗リンホトキシン感受性疾患剤
JP2518634B2 (ja) ヒト ツモア・ネクロシス・フアクタ−の製造方法
JP2518635B2 (ja) ヒト ツモア・ネクロシス・フアクタ−
KR950008569B1 (ko) 신규 림포카인(lymphokine) 및 그 제조방법과 사용방법
JP2532025B2 (ja) 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
JP2926409B2 (ja) 癌転移抑制因子の製造方法
KR900005860B1 (ko) 인간의 면역응답 억제인자의 제조방법
JPS5889195A (ja) 標的細胞障害性因子の製造方法
KR970002165B1 (ko) γ-인터페론의 제조방법과 그 용도
KR830001817B1 (ko) 타이프ⅱ 인터페론의 제조방법
KR820001174B1 (ko) 사람 특이성 인터페론의 제조법
WO2022201047A1 (en) New treatment of sepsis
EP4079312A1 (en) New treatment of sepsis
JPS61115027A (ja) 新リンホカイン２とその製法および用途